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Gastric cancer is most common cancer in Korea. Surgery is still the main axis of treatment. Due to early detection of gastric 
cancer, the innovation of surgical instruments and technological advances, gastric cancer treatment is now shifting to a new 
era. One of the most astonishing changes is that minimally invasive surgery (MIS) is becoming more dominant treatment for 
early gastric cancer. These MIS are represented by endoscopic resection, laparoscopic surgery, robotic surgery, single-port 
surgery and natural orifice transluminal endoscopic surgery. Among them, laparoscopic gastrectomy is most actively per-
formed in the field of surgery. Laparoscopy-assisted distal gastrectomy (LADG) for early gastric cancer (EGC) has already 
gained popularity in terms of the short-term outcomes including patient’s quality of life. W e only have to wait for the 
long-term oncologic results of Korean Laparoscopic Gastrointestinal Surgery Study Group. Upcoming top issues following 
oncologic safety of LADG are function-preserving surgery for EGC, application of laparoscopy to advanced gastric cancer 
and sentinel lymph node navigation surgery. In the aspect of technique, laparoscopic surgery at present could reproduce al-
most the whole open procedures. However, the other fields mentioned above need more evidences and experiences. All 
these new ideas and attempts provide technical advances, which will minimize surgical insults and maximize the surgical 
outcomes and the quality of life of patients. 
Key Words: Gastric cancer, Future perspective, Laparoscopy, Sentinel lymph node navigation surgery, Minimally invasive 
surgery
INTRODUCTION
Gastric cancer is still a major health problem and lead-
ing cause of cancer death in spite of decreasing worldwide 
incidence. About one million new cases of stomach cancer 
were estimated to have occurred in 2008 (988,000 cases, 
7.8% of the total cancer), making it the fourth most com-
mon malignancy in the world. Moreover, stomach cancer 
is the second leading cause of cancer death in both sexes 
worldwide (736,000 deaths a year, 9.7% of the total) [1]. 
Gastric cancer is also the most common cancer and annu-
ally affects over 25,000 patients in Korea, where the in-
cidence is stationary or slightly decreased. In addition, it is 
the second leading cause of cancer death after lung cancer, Hyung-Ho Kim and Sang-Hoon Ahn
152 thesurgery.or.kr
and is up to over 10,000 deaths a year [2,3]. There are nota-
ble changes over the past 20 years. The proportion of early 
gastric cancer (EGC) and proximal gastric cancer has in-
creased continuously from 24.8 to nearly 50% and from 5.3 
to 14.0%, respectively. Proximal EGC consisted of 30.3% of 
total proximal gastric cancer while distal EGC consisted of 
51.5% of total distal gastric cancer [4,5]. There is also in-
creasing trend of older gastric cancer patients due to in-
creased average life expectancy. Owing to early detection 
of the disease, the results of treatment for gastric cancer 
have improved in Korea. The survival rate of gastric can-
cer has been increased from 64.0% in the late 1980s to 
73.2% in the early 2000s [4]. 
As the proportion of EGC and the age of gastric cancer 
patients have increased, accordingly, more and more sur-
geons are interested in minimally invasive surgery repre-
sented by endoscopic resection, laparoscopic gastrectomy. 
Among them, laparoscopic gastrectomy is most actively 
performed in the field of surgery. Laparoscopy-assisted 
gastrectomy in distal EGC has already gained an accept-
ance with respect to minimal invasiveness and a suitable 
alternative method to open surgery. Recently, experienced 
surgeons are trying to extend the application of this lapa-
roscopic approach to certain advanced gastric cancer 
(AGC) using more aggressive laparoscopic techniques. On 
the contrary, there is a larger trend of adopting these tech-
niques to sentinel lymph node navigation surgery (SNNS) 
for more minimizing surgical extent. On the other side, ro-
botic surgery, single port surgery and natural orifice trans-
luminal endoscopic surgery (NOTES) is gradually being 
applied to clinical fields for investigational purposes. The 
purpose of this article is to review these top issues and the 
current status with literature review to propose the future 
of laparoscopic gastric surgery. 
LAPAROSCOPIC GASTRECTOMY IN DIS-
TAL EGC
Considering the excellent prognosis of EGC, the quality 
of life after operation has been focused on these patients. 
For the better quality of life, laparoscopic gastrectomy has 
emerged as an alternative treatment option for EGC 
patients. Since Kitano first performed laparoscopy-as-
sisted distal gastrectomy (LADG) for EGC in 1991, it has 
been performed worldwidely, especially in Korea and 
Japan. According to the Korean Laparoscopic Gastrointes-
tinal Surgery Study Group (KLASS) survey, 3,783 laparo-
scopic gastric cancer surgeries (25.8% of total gastric can-
cer operations) were performed during 2009. The number 
of surgeries in 2009 is almost five times more than that of 
2004. The cumulative number from 1995 to 2009 was about 
14,731. Laparoscopic procedures for gastric cancer were 
widely adopted in Korea since 2006 because laparoscopic 
procedures could be reimbursed by health insurance [5]. 
The purposes of laparoscopic surgery for gastric cancer 
are to minimize surgical insults and to maximize patient’s 
quality of life, while not influencing radicality. A number 
of reports have presented the excellent short term out-
comes; less postoperative pain, improved cosmetics, less 
inflammatory reaction, a good preserved immune func-
tion, a rapid recovery of bowel function, shorter hospital 
stay, and a rapid return to normal social activity [6-9]. Most 
reports on laparoscopic distal gastrectomy were retrospec-
tive studies, and many retrospective multicenter studies 
about laparoscopic gastric surgery were conducted in 
Korea [10-13] (Table 1). According to Korean a retrospec-
tive multicenter study, morbidity and mortality were 
13.1% and 0.7% [10]. Of course, there are 6 available pro-
spective randomized controlled trials (RCT) for preli-
minary results worldwidely (Table 2). But even these stu-
dies have many limitations (e.g. limited trial numbers, 
non-multicenter, small sample size, conflicting results 
etc.). In Korea, two small sized RCTs comparing LADG 
and open distal gastrectomy (ODG) already has been 
reported [9,14] and KLASS trial, which is the first multi- 
center, large-scale, prospective, randomized controlled 
study is going on briskly. According to the interim analy-
sis of KLASS trial including 179 LADG and 163 ODG 
patients, there was no significant difference between two 
groups in terms of age, gender, and comorbidity. Post-
operative complication rates of LADG and ODG groups 
were 10.5% (17/179) and 14.7% (24/163), respectively (P = 
0.137). Postoperative mortality was 1.1% (2/179) in LADG 
and 0% (0/163) in ODG patients (P = 0.497). There was no 
significant difference of morbidity and mortality betweenLaparoscopic surgery for gastric cancer
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LADG and ODG patients [6]. 
However, despite of the favorable results of all of the 
above studies, there is little evidence of long-term onco-
logical outcome of laparoscopic gastrectomy as a treat-
ment modality for gastric cancer. Even in a revised 2011 
English version of the Japanese gastric cancer treatment 
guideline 3
rd edition, to be published 15 years after the first 
case of laparoscopic gastrectomy, laparoscopic gastrec-
tomy is still classified as an investigational treatment eligi-
ble for EGC [15]. In the early 2000s, phase III evidence be-
gan to emerge in Western countries for colon cancer dem-
onstrating that the oncologic outcomes of laparoscopic co-
lon operation are similar to those of open colon operation 
and the new procedure is associated with less pain and 
shorter hospital stay. Undoubtedly, most surgeons have 
now accepted laparoscopic surgery for colon cancer. In 
contrast, the long-term results of multi-center randomized 
controlled trials of laparoscopic versus open gastrectomy 
are needed to establish the future role of laparoscopic sur-
gery in the treatment of patients with gastric cancer. The 
KLASS trial completed the enrollment of patients in 2010. 
We now have to wait for the long-tern results of KLASS 
study in 2015. Another RCT to compare long- term surviv-
al after open and laparoscopic gastrectomy for EGC are 
currently ongoing in Japan (JCOG 0912 trial). If the result 
of these two trials will be positive, the laparoscopic gas-
trectomy will be a standard method for distally located 
EGC like the clinical outcomes of surgical therapy (COST) 
study group trial did in colon cancer [16].
In the view of laparoscopic techniques for distal gastric 
cancer, there are some trends of moving from extra- corpo-
real anastomosis to an intra-corporeal fashion to get rid of 
mini-laparotomy for improving the quality of life of 
patients. Totally laparoscopic distal gastrectomy (TLDG) 
with delta-shape anastomosis is a representative proce-
dure. In one retrospective study, it was suggested that 
TLDG contributes to the improvement of early surgical 
outcomes, more interestingly, TLDG in obese patients 
could be the best way to improve early surgical outcomes, 
including the bowel movement, pain score, overall com-
plication rate [17]. In another study which was pro-
spective, non-randomized with small numbers of cases, 
no significant difference was found in mean operative 
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time, estimated blood loss, or immunologic or inflam-
matory markers between TLDG and LADG. However, 
time to first meal was significantly shorter in the TLDG 
group than either LADG or ODG but TLDG needed more 
cost [18]. Intra-corporeal anastomosis without mini-lapa-
rotomy is gaining more popularity. However, to prove su-
periority of this procedure over LADG, phase III trials are 
required.
In the aspect of reconstruction methods, the Billroth I 
procedure was most frequently performed after distal gas-
trectomy (63.4%), followed by Billroth II (33.1%) in Korea 
in 2009. Roux-en-Y gastrojejunostomy was only perfor-
med in 3.3% [5]. When we choose the reconstruction meth-
ods, we should consider whether the patient suffers from 
type 2 diabetes or not. Recently, in the management of type 
2 diabetes, bariatric surgery (Roux-en-Y Gastric Bypass 
Procedure [RYGBP] and Laparoscopic Adjustable Gastric 
Banding) was added to the treatment guidelines of Inter-
national Diabetes Federation for type 2 diabetes [19]. The 
proposed mechanism is that by bypassing duodenum and 
proximal jejunum, loss of the signals causing insulin re-
sistance is achieved (foregut hypothesis) and fast reach to 
hindgut cause early signal for glucose control (hindgut hy-
pothesis) [20]. In the patients of gastric cancer with type 2 
diabetes and high body mass index, Roux-en-Y gastro-
jejunostomy method is expected to be better than Billroth 
I methods to resolve type 2 diabetes and obesity [21]. In 
one study from Japan, they reported that Roux-en-Y re-
construction after distal gastrectomy seems superior to 
Billroth-I reconstruction for preventing both bile reflux in-
to the gastric remnant and postoperative complications. 
They concluded R-Y reconstruction was a feasible and safe 
method for LADG [22]. 
LAPAROSCOPIC FUNCTION PRESERVING 
GASTRECTOMY
Pylorus-preserving gastrectomy (PPG) has not been 
widely performed in Korea. In the Korean national survey 
2009, PPG was only performed in 86 cases (0.6%), which 
was less than PG [5]. There has been no consensus about 
PPG in Korea mainly because of extremely rare operations 
in Korea. It is originally treatment option in gastric ulcer 
surgery, which has several benefits compared to distal gas-
trectomy like the lower incidence of dumping syndrome, 
bile reflux, gall stone, and the significant decrease in post-
operative weight loss [23]. But these benefits have not yet 
been proven by prospective randomized trials. Park et al. 
[24] reported PPG has many advantages than Billroth I 
such as the gastric emptying, bile reflux and gall stone, 
which was mostly due to the preservation of hepatic 
branch of vagus nerve and pylorus. PPG patients also had 
fewer subjective postprandial symptoms than Billroth I 
patients. Another report on laparoscopy-assisted pylo-
rus-preserving gastrectomy (LAPPG) concluded that 
LAPPG is a safe operation with minimized complications 
based on Clavien-Dindo classification for the middle third 
EGC. But surgeons need to ensure an extra learning curve 
for LAPPG [25]. In Korea, cases of PPG are so very rare that 
the data of PPG is not available to some conclusions. In the 
laparoscopic gastric surgery era, PPG could be another 
fascinating treatment option for middle third EGC. But we 
need a greater level of evidence. It is necessary to give 
more regards to LAPPG and organize multicenter pro-
spective RCTs in Korea. 
For proximal EGC, total gastrectomy is regarded as a 
standard method in Korea. But even laparoscopy-assisted 
total gastrectomy has not been performed widely due to 
technical difficulty. It’s only recent that laparo-
scopy-assisted total gastrectomy has increased in the 
number of cases in Korea (20 cases in 2003, 112 cases in 
2004 and 231 cases in 2008). By comparison, laparo-
scopy-assisted proximal gastrectomy (LAPG) has been 
performed rarely to this day. Even including the cases of 
open gastrectomy, proximal gastrectomy were performed 
only in 141 (1.0%) patients in Korea [5]. In the concept of 
minimally invasive surgery and function-preserving pro-
cedure, LAPG is theoretically ideal. A lot of functional 
benefits have been reported in the several reports; im-
proved postoperative fat absorption, improved nutrition, 
preventing anemia, releasing of gut hormones and re-
ducing postoperative complaints [26,27]. Oncologic con-
cerns have also been solved to some degree by several re-
ports in proximal gastrectomy, showing the similar 
long-term oncologic outcomes even in AGC [28]. But most Hyung-Ho Kim and Sang-Hoon Ahn
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gastric surgeons are afraid of performing proximal gas-
trectomy because of the infamous complications such as 
anastomotic stricture and reflux esophagitis [29-31]. To 
overcome these complications, various reconstruction 
methods have been developed so far. These methods were 
mainly classified into two categories (esophago-gastro-
stomy versus esophago-jejunostomy). The incidence of 
anastomotic stricture was mainly higher in gastro-esoph-
agostomy methods than in esophago-jejunostomy, espe-
cially in end-to-end esophago-gastrostomy. The mecha-
nisms of anastomotic strictures are not known. Proposed 
mechanisms are causation by reflux esophagitis and the 
discrepancy of wall thickness between esophagus and 
stomach. In the case of reflux esophagitis, rates were re-
ported in a wide range from 7 to 50% mainly because of the 
different diagnostic criteria of reflux esophagitis and the 
selection bias of retrospective studies. Actually, there are 
no prospective reports analyzing the incidence and patho-
physiology of reflux esophagitis after proximal gastrec-
tomy. 
Our recent data showed a feasibility and acceptability of 
LAPG by retrospective analysis in LAPG of 52 cases com-
paring with LATG of 82 cases. In this study, early compli-
cation rates after LAPG and LATG were 23.1% and 17.1%, 
respectively, which was insignificant. The overall inci-
dence of reflux esophagitis were about 30.8% in the overall 
LAPG group and about 3.7% in the LATG group (P ＜ 
0.001). But the clinical outcomes of late phase of LAPG (n 
= 13) were superior to LATG (shorter operative time, 198.0 
vs. 242.2 minutes P ＜ 0.001; similar early complication 
rate, 15.4% vs. 17.1% P = 0.880; similar reflux symptoms, 
7.7% vs. 3.7% P = 0.083; less body weight loss, -3.4 vs. -6.3 
kg P = 0.026). Recently, esophago-jejunstomy with a dou-
ble tract reconstruction or jejunal interposition after prox-
imal gastrectomy showed acceptable rates of anastomotic 
stricture and reflux esophagitis comparing with total gas-
trectomy [32].  
LAPAROSCOPY-ASSISTED TOTAL GAST-
RECTOMY
LATG remains challenging under the laparoscopic ap-
proach and the technique has not been standardized. The 
incidence of complications is reported to be higher com-
paring with LADG, and a reliable method of esoph-
ago-jejunostomy is still key issues [33]. So, some gastric 
surgeons prefer open total gastrectomy to laparoscopic 
methods. This preference mainly comes from the diffi-
culty of esophago-jejunostomy (E-Jstomy) in laparoscopy 
settings. There are several methods for reconstruction af-
ter LATG. Reconstruction methods for bowel continuity 
are largely two kinds. One is extracorporeal method using 
conventional open purse-string clamp and circular stapler 
through mini-laparotomy at epigastrium, which is similar 
to conventional open surgery and has been commonly 
performed after LATG [34]. But, in this method it is quite 
difficult to apply conventional purse-string clamp and to 
obtain enough proximal resection margin due to poor vis-
ualization of fields, especially in obese patients. The other 
is the intracorporeal method, which means the transection 
of esophagus is performed under laparoscopy vision. The 
esophagus transection is made by linear stapler or laparo-
scopic purse-string clamp (Endo-PSI, Hope Electronics, 
Chiba, Japan; Lap-Jack, Eterne, Seongnam, Korea) or semi-
automatic suturing device (Endostitch, Covidien, Man-
sfield, MA, USA). In the case of linear stapler transection, 
the E-Jstomy is done by linear stapler in side to side fash-
ion or by OrVil (Covidien) and circular stapler. In the case 
of using laparoscopic purse-string clamp, the E-Jstomy is 
done by circular stapler. Transoral introduction of the an-
vil head of the circular stapler seems to be a recent in-
novation that is promising [35]. Another group reported 
the initial experience of application of the delta-shaped 
anastomosis to E-Jstomy, which is intracorporeal anasto-
mosis, without mini-laparotomy. [36].
In our retrospective study, which was a relatively large 
number of cases, comparative analysis of short-term out-
comes between extracorporeal end-to-side E-Jstomy and 
intracorporeal side-to-side E-Jstomy was done. We con-
cluded by this study that end-to-side E-Jstomy using cir-
cular stapler could be recommended after LATG because 
E-Jstomy leakage rates (14.3% vs. 2.2%, P = 0.043) after 
side-to-side E-Jstomy by linear stapler & intracorporeal 
suture was higher than end-to-side E-Jstomy [37]. Based 
on these results, we changed the anastomosis methods to Laparoscopic surgery for gastric cancer
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intracorporeal end-to-side E-Jstomy using by laparo-
scopic purse-string clamp (LapJack, Eterne) and circular 
stapler. After the application of LapJack, there has been no 
anastomotic problems, including leakage, in the consec-
utive 50 cases, which is very promising.
However, the optimal procedures for reconstruction 
methods after LATG have yet to be established [36]. And 
there have been a few reports on this subject. We need 
more advanced, novel instruments such as deployable sta-
pler and techniques for the application for LATG or totally 
laparoscopic total gastrectomy.
LAPAROSCOPIC SURGERY FOR AGC
 Open surgery has been the standard method for AGC 
for over 100 years. There are no evidences of the applica-
tion of laparoscopic approach in AGC at present. Techni-
cal feasibility of laparoscopy gastrectomy for AGC largely 
depends on the applicability and safety of D2 lymph node 
dissection, which is regarded as a standard for AGC in 
Korea and Japan. Recently, several experienced surgeons 
have tried to extend the application of laparoscopy- as-
sisted gastrectomy for AGC. In some studies, the short- 
term and the long-term outcomes after laparoscopy-as-
sisted gastrectomy for AGC were non-inferior to open 
surgery. But these were small size, retrospective studies 
with many biases [38,39]. One RCT and one retrospective 
case controlled study including advanced gastric cancer 
showed that there was no significant difference between 
two groups in terms of the number of resected lymph no-
des, recurrence and survival [7,40]. One retrospective sin-
gle center study demonstrated that five-year overall sur-
vival rate was 81.4% [41]. These retrospective data has se-
lection bias that preoperative stage was cT2 or less than 
cT2 but final pathologic stage was T2 or more than T2. 
If the same extents of resection and lymph node dis-
section (LND) comparing with open surgery could be per-
formed, the oncological results theoretically would be the 
equivalent to open surgery. In the aspect of technique, lap-
aroscopic surgery could reproduce almost the whole of 
open procedures. Although laparoscopic gastrectomy 
with D2 LND is being performed for patients with locally 
advanced gastric cancer, the completeness of the D2 LND 
during laparoscopic surgery has not been evaluate and no 
standardized procedure exists. Soon, a multicenter, pro-
spective randomized study about LADG for AGC in 
Korea (KLASS-02 study) is to start. To conduct a clinical 
trial comparing laparoscopic D2 LND to the open ap-
proach, quality control of D2 LND is necessary. Only expe-
rienced laparoscopic gastric surgeons will have been in-
vited to participate in KLASS-02 trial. They must be vali-
dated by peer reviewer’s evaluation of unedited video re-
cording of three open gastrectomies and three laparo-
scopic gastrectomies to predetermined criteria, which is fi-
nally approved by review committee. This trial was regis-
tered as KLASS-02-QC trial at www.clinicaltrials.gov 
(NCT00452751). After the confirmation of the results of 
this study, main KLASS-02 study of LADG for AGC can be 
started without the criticism of appropriacy of D2 LND.  
SNNS IN LAPAROSCOPIC ERA
Stage I gastric cancer accounts for approximately 50% of 
all surgically resected cases in Korea [4]. Because lymph 
node metastases occur in only 5 to 20% of patients with 
early gastric cancer, reduction of the extent of lymph node 
dissection and gastric resection would be beneficial if it 
were possible to predict the direction of lymph node 
metastasis. SNNS is now widely available as reduction 
surgery for breast cancer. But SNNS is still in its infancy in 
gastric cancer area. A sentinel node (SN) is defined as the 
lymph node that is first to receive the flow of lymphatic 
fluid from the area containing the primary tumor of an 
organ. According to the SN hypothesis, lymph node dis-
section can be omitted when no metastasis are detected in 
SNs. Sentinel basin represent all the lymphatic stations to 
which SNs belong. Sentinel node identification is usually 
performed with radioactive tin colloid and/or indoc-
yanine green (ICG). To use SNNS in clinical practice, skip 
metastases and false negative rate are crucial points. In 
gastrointestinal malignancies, the appearance of lymph 
node metastasis is not constant mainly because of the ex-
istence of multiple and complex lymphatic routes. There is 
a report in which skip metastases is occurred in 20 to 30% Hyung-Ho Kim and Sang-Hoon Ahn
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Fig. 1. Protocol of sentinel lymph node navigation surgery in Seoul 
National University Bundang Hospital. EUS, endoscopic ultra-
sonography; CT, computed tomography; RI, radioisotope; H&E, 
hematoxylin & eosin; IHC, immunohistochemistry.
of gastric cancer [42]. In one large prospective multicenter 
trial of sentinel node mapping for gastric cancer, Kitagawa 
et al [43]. reported at ASCO in 2009 that the detection rates 
was 97.5% (387/397), the mean numbers of SNs 5.6 and the 
sensitivity and the accuracy was 93% (53/57) and 99% (383/ 
387), respectively. There were 4 cases of false-negative cas-
es; among them, 2 cases were T2 and 3 cases were on same 
basin. Their eligible criteria were that patients had clin-
ically T1-2N0M0 single tumor with diameter of primary 
lesion less than 4 cm without any previous treatment. 
They used radioactive tin colloid and isosulfan blue for 
dual traces. 
In our series, we initially used indocyanine green and 
99mTc-tin colloid (separate injections in the first phase, n = 
16) and later indocyanine green and 
99mTc-ASC (simulta-
neous injections in the second phase, n = 52) (Fig. 1). The 
SNs were identified in 62 of the 68 patients (91.2%; mean 
3.3 per patient) with gastric cancer, and the sensitivity and 
specificity of SNNS was elevated to 100% by using the dual 
dye methods and basin dissection. If there are no meta-
stasis in SNs in basins, no further dissection is necessary, 
which means that the hepatic and celiac branch of vagus 
nerve and parasympathetic nerve to small bowel can be 
saved, so it guarantee gastric and small bowel motility 
function [44]. In the near future, most of EGC patients will 
be treated by one-stop intraoperative endoscopic sub-
mucosal dissection plus SNNS rather than the extensive 
resection and lymph node dissection in the way modified 
radical mastectomy with axillary lymph node dissection 
has migrated to the lumpectomy with SNNS in breast can-
cer [44].
ROBOTIC SURGERY IN GASTRIC CANCER
Robotic surgery has recently emerged as a newer mini-
mally invasive technique that may offer surgeons techni-
cal solution to the limitations of conventional laparoscopy 
surgery. These solutions consist of a steady camera plat-
form with 3D imaging, surgical instrument with high de-
gree of angulation, filtration of resting tremor and an ergo-
nomically comfortable surgeon’s position. Another most 
important aspect of robotic surgery is that it enables per-
formances of so called “telesurgery” or “remote surgery”. 
It promises to allow the expertise of specialized surgeons 
to be available to patients worldwide, without the need for 
patients to relocate.
Robotic surgery was applied to the fields of gastric can-
cer in Korea earlier than in other country. There have been 
installed about 50 da Vinci systems in 20 institutions until 
now. Robotic gastrectomy’s greatest advantages are in fine 
manipulations as in D2 lymph node dissection and intra-
corporeal anastomosis. But there are many disadvantages. 
Not only the lack of tactile sense, but also its macroscopic 
manipulation speeds and shift of scene are not quick 
enough. Experienced surgeons accustomed to laparo-
scopy speeds, dexterity, and tactile sense may feel that ro-
bot gastrectomy have no advantages over laparoscopy 
gastrectomy. 
Currently, there are little evidences supportive of ro-
botic gastrectomy. Some retrospective studies with early 
experiences in Korea have been reported gradually. There 
were no significant differences in the complication rate 
amongst the open, laparoscopic, or robotic group. Howev-
er, while the estimated blood loss and post-operative hos-
pital stay were significantly less than in the robotic group, 
the operative time was significantly longer. Furthermore, Laparoscopic surgery for gastric cancer
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with respect to performing D2 lymphadenectomy, sur-
geons found the dissection around major vessels to be eas-
ier robotically due to the stability of the camera, the articu-
lation of the operating arms, and the 3-D, magnified view 
[45].
We must try to identify the beneficial aspects of patients 
but its cost is too high to study large number of patients. 
So, to begin with, we should focus on cost-cutting of cur-
rent robotic surgery, such as localization of laparoscopic 
robot to abolish the monopoly of da Vinci. We must lead in 
the field of robotic gastrectomy and make the evidences of 
robot gastrectomy by balancing costs with its effective-
ness, as there are a few cases of robotic gastrectomy out-
side Korea. The Multi-institutional prospective study on 
the assessment of robotic surgery for gastric cancer in 
Korea is now proceeding according to plan. It is certain 
that robotic surgery will become an additional option in 
minimally invasive surgery.
NEW EMERGING TECHNIQUES
Single incision laparoscopic surgery (SILS) was devel-
oped to reduce the minimal invasiveness of laparoscopy to 
an ultra-minimal invasiveness and to achieve excellent 
cosmesis. The SILS has been performed in various sur-
geries such as cholecystectomy, appendectomy, colec-
tomy, sleeve gastrectomy for morbid obesity [46,47]. Very 
recently, there was the first report on successful single-in-
cision laparoscopic gastrectomy for EGC [48]. They used a 
vertical 2.5-cm intraumbilical incision with two 2-mm 
mini-loop retractor. All seven cases with single-incision 
laparoscopic distal gastrectomies (SIDG) were performed 
without conversion to LADG or open gastrectomy. The 
median operative time was 344 minutes (range, 282 to 385 
minutes). They showed that SIDG was a feasible and safe 
procedure for EGC and gives a favorable cosmetic result. 
Further research is warranted to evaluate the safety and 
feasibility of SIDG. Our team also had the experiences of 
two SIDG cases followed by experimental study “SIDG vs. 
LADG in a porcine model” which is going to be published 
soon. Eventually, after further development of smart in-
struments with 5-mm flexible scopes, which could possi-
bly be used in single port, for example, it will be the time 
that SILS become the optional treatment for gastric cancer. 
It currently remains in experimental stages.
Natural Orifice Transluminal Endoscopic Surgery has 
increasingly been reported as the future new technique to 
laparoscopic surgery. A few reports have emerged report-
ing a hybrid approach using transvaginal NOTES techni-
que with laparoscopic assistance in the partial gas-
trectomy of submucosal tumor, with removal of the speci-
men through the vagina [49]. Several proposals for trans-
gastric resection or lymph node biopsy or dissection have 
also been proposed via NOTES technique [50]. But there 
are many criticisms of this proposal for which oncologic 
safety needs to be considered. There is no role for NOTES 
for gastric cancer yet.
CONCLUSION
Gastric cancer treatment is now moving on to a new era. 
This is a major evolution since Billroth performed the first 
successful gastrectomy in 1881. Present data indicate that 
the treatment of gastric cancer has more and more in-
dividualized with various tailored therapies. As laparo-
scopic experience has been accumulated, the indications 
for laparoscopic gastrectomy have been greatly 
broadened. Advanced laparoscopic techniques for gastric 
cancer, such as laparoscopy-assisted total gastrectomy, 
laparoscopy-assisted proximal gastrectomy, laparoscopic 
SNNS, and laparoscopic D2 lymph node dissection for 
AGC will have been more broadly performed in the near 
future. Additionally, robotic surgery, single port surgery 
and natural orifice transluminal endoscopic surgery 
(NOTES) will become additional options in minimally in-
vasive surgery much as the validation needs to be used in 
clinical fields. 
Another important thing is education. As the number of 
laparoscopic gastric surgeries has increased rapidly, the 
importance of education for laparoscopic skills became 
higher. Because many active domestic training workshops 
have been actively held in Korea, novices can easily and 
quickly overcome the learning curve in laparoscopic gas-
tric surgery. More refined domestic training workshops Hyung-Ho Kim and Sang-Hoon Ahn
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and international collaborations including animal or ca-
daveric surgical models will promise to progress ad-
vanced laparoscopic gastric surgery. All these efforts and 
technical advancements will finally improve the survival 
and the quality of life of patients suffering from gastric 
cancer.
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